Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking.

about

Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking.

Item

http://www.wikidata.org/entity/Q47828100

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Anti-PD-1/anti-CTLA-4 efficacy ...... on of CD8+ T cell trafficking.

@en

Anti-PD-1/anti-CTLA-4 efficacy ...... on of CD8+ T cell trafficking.

@nl

type

Item

label

Anti-PD-1/anti-CTLA-4 efficacy ...... on of CD8+ T cell trafficking.

@en

Anti-PD-1/anti-CTLA-4 efficacy ...... on of CD8+ T cell trafficking.

@nl

prefLabel

Anti-PD-1/anti-CTLA-4 efficacy ...... on of CD8+ T cell trafficking.

@en

Anti-PD-1/anti-CTLA-4 efficacy ...... on of CD8+ T cell trafficking.

@nl

P1154

2-s2.0-85042010624

http://www.w3.org/2001/XMLSchema#string

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Anti-PD-1/anti-CTLA-4 efficacy ...... on of CD8+ T cell trafficking.

@en

P2093

Mihaela Lorger

http://www.w3.org/2001/XMLSchema#string

Nora Rippaus

http://www.w3.org/2001/XMLSchema#string

Rebecca J Brownlie

http://www.w3.org/2001/XMLSchema#string

Tereza Andreou

http://www.w3.org/2001/XMLSchema#string

P2860

Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

CNS immune privilege: hiding in plain sight.

Immunotherapy for cancer in the central nervous system: Current and future directions

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination.

Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8(+) T cells directly within the tumor microenvironment.

Role of the cervical lymphatics in the Th2-type hierarchy of CNS immune regulation.

Guidelines for the welfare and use of animals in cancer research.

Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.

P31

scholarly article

P356

10.1073/PNAS.1714089115

http://www.w3.org/2001/XMLSchema#string

P407

English

P50

P5530

32553964

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100741894

http://www.w3.org/2001/XMLSchema#string

P6409

153791870

http://www.w3.org/2001/XMLSchema#string

P698

29386395

http://www.w3.org/2001/XMLSchema#string

P932

5816160

http://www.w3.org/2001/XMLSchema#string

P953

127020